These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17322894)

  • 1. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure.
    Lymperopoulos A; Rengo G; Funakoshi H; Eckhart AD; Koch WJ
    Nat Med; 2007 Mar; 13(3):315-23. PubMed ID: 17322894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Femminella G; Liccardo D; Pagano G; de Lucia C; Cannavo A; Gargiulo P; Ferrara N; Perrone Filardi P; Koch W; Leosco D
    Br J Pharmacol; 2012 Aug; 166(8):2430-40. PubMed ID: 22519418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-distance affair with adrenal GRK2 hangs up heart failure.
    Liggett SB
    Nat Med; 2007 Mar; 13(3):246-8. PubMed ID: 17342115
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
    Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
    J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.
    Rengo G; Leosco D; Zincarelli C; Marchese M; Corbi G; Liccardo D; Filippelli A; Ferrara N; Lisanti MP; Koch WJ; Lymperopoulos A
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2032-8. PubMed ID: 20304818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells.
    Jafferjee M; Reyes Valero T; Marrero C; McCrink KA; Brill A; Lymperopoulos A
    Mol Endocrinol; 2016 Mar; 30(3):372-81. PubMed ID: 26849467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
    Kamal FA; Mickelsen DM; Wegman KM; Travers JG; Moalem J; Hammes SR; Smrcka AV; Blaxall BC
    J Am Coll Cardiol; 2014 Jun; 63(23):2549-2557. PubMed ID: 24703913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat.
    Theilade J; Strøm C; Christiansen T; Haunsø S; Sheikh SP
    Basic Res Cardiol; 2003 Mar; 98(2):97-103. PubMed ID: 12607131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.
    Matkovich SJ; Diwan A; Klanke JL; Hammer DJ; Marreez Y; Odley AM; Brunskill EW; Koch WJ; Schwartz RJ; Dorn GW
    Circ Res; 2006 Oct; 99(9):996-1003. PubMed ID: 17008600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal adrenoceptors in heart failure.
    de Lucia C; Femminella GD; Gambino G; Pagano G; Allocca E; Rengo C; Silvestri C; Leosco D; Ferrara N; Rengo G
    Front Physiol; 2014; 5():246. PubMed ID: 25071591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function.
    Vinge LE; Andressen KW; Attramadal T; Andersen GØ; Ahmed MS; Peppel K; Koch WJ; Freedman NJ; Levy FO; Skomedal T; Osnes JB; Attramadal H
    Mol Pharmacol; 2007 Sep; 72(3):582-91. PubMed ID: 17573483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy.
    Cannavo A; Liccardo D; Koch WJ
    Front Physiol; 2013 Sep; 4():264. PubMed ID: 24133451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity.
    Lymperopoulos A; Rengo G; Zincarelli C; Soltys S; Koch WJ
    Mol Ther; 2008 Feb; 16(2):302-7. PubMed ID: 18223549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure.
    McCrink KA; Brill A; Lymperopoulos A
    World J Cardiol; 2015 Sep; 7(9):539-43. PubMed ID: 26413230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?
    Bencivenga L; Palaia ME; Sepe I; Gambino G; Komici K; Cannavo A; Femminella GD; Rengo G
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation.
    Lymperopoulos A; Rengo G; Koch WJ
    Trends Mol Med; 2007 Dec; 13(12):503-11. PubMed ID: 17981507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 Regulates α
    Cannavo A; Liccardo D; Lymperopoulos A; Santangelo M; Femminella GD; Leosco D; Cittadini A; Ferrara N; Paolocci N; Koch WJ; Rengo G
    J Am Coll Cardiol; 2017 Mar; 69(11):1515-1517. PubMed ID: 28302297
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.